Research Progress on Antimicrobial Resistance (AMR)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 30 October 2026 | Viewed by 1371
Special Issue Editor
Interests: antibiotic resistance mechanisms; multidrug-resistant bacterial infections; strategies for antibiotic resistant bacterial infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) is currently a global concern. During the COVID-19 pandemic, infectious disease specialists focused on the prevention and control of COVID-19, and strict infection control served to restrict the spread of endemic infectious diseases. However, following COVID-19, many endemic infectious diseases emerged again, and several cases of antimicrobial resistance have been reported. For example, carbapenem-resistant Enterobacteriaceae (CRE) infections have been increasing, and drug therapy is currently limited. Therefore, identifying AMR pathogens is of paramount importance. In addition to severe and hospitalized infections such as CRE, community-acquired infections such as Mycoplasma pneumoniae infections and pertussis have also increased, along with macrolide-resistant isolates. Hence, this Special Issue addresses the increasing prevalence of antimicrobial resistance infections, highlights their current therapies, and identifies future challenges. We welcome research on all aspects of AMR, including the mechanism of resistance and therapeutic strategies.
Prof. Dr. Tomohiro Oishi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- mechanism
- therapy
- experiment
- bacteria
- antibiotics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
